HYAMIRA FORTE (1x1ml) NYUMA APHARM

Hyamira

Injectable dermal filler

Cross-linked hyaluronic acid volumizing filler for medium-to-deep wrinkles and facial contouring

CE Marked class III medical device based on cross Linked hyaluronic acid for injectable facial augmentation and wrinkle correction (as per EU medical device classification for such fillers).
Manufactured in Italy in compliance with European medical device regulations and ISO Aligned quality management systems for sterile injectable products.
Non Animal Origin hyaluronic acid with strict controls on residual cross Linking agent (BDDE < 50 ppb) and low protein content, supporting high biocompatibility.

CE Marked class III medical device based on cross Linked hyaluronic acid for injectable facial augmentation and wrinkle correction (as per EU medical device classification for such fillers).
Manufactured in Italy in compliance with European medical device regulations and ISO Aligned quality management systems for sterile injectable products.
Non Animal Origin hyaluronic acid with strict controls on residual cross Linking agent (BDDE < 50 ppb) and low protein content, supporting high biocompatibility.
Intended exclusively for professional medical use in accordance with local aesthetic medicine regulations and professional guidelines.

Description

Hyamira FORTE (1x1ml) NYUMA APHARM is a CE-marked, colourless monophasic dermal filler gel based on cross-linked, non-animal hyaluronic acid. With a high HA concentration (labelled 25 mg/ml in technical descriptions, with some documentation listing 24 mg/ml), it is intended for the treatment of medium-to-deep facial wrinkles and folds, and for volumetric correction and reshaping of key facial structures including cheekbones, chin, bridge of the nose and lips. Injected into the deep hypodermis or onto the periosteum, Hyamira Forte restores lost facial volume, redefines the facial oval, reduces pronounced wrinkles, and provides deep hydration and elasticity. Its homogeneous texture and strongly reticulated HA provide a powerful, long-lasting volumizing and bio-revitalising effect while maintaining natural facial expression.

Bnefits

Treats medium-to-deep facial wrinkles and folds with a high-viscosity, strongly cross-linked HA gel.
Restores and enhances facial volumes in areas such as cheekbones, chin, nose and lips.
Redefines the facial oval and improves overall facial contours.
Provides deep hydration and improves skin elasticity, contributing to a smoother, firmer appearance.
Homogeneous monophasic texture allows effective filling of moderate-to-severe wrinkles and structural depressions.
Non-animal, biodegradable, low-protein cross-linked HA formulation designed to minimise immunogenicity and maintain natural facial movement.
Long-lasting effect, with clinical distributors indicating results around 9–12 months and some documentation suggesting up to 12–14 months depending on patient factors.
Part of a structured range (SOFT–BASIC–FORTE) that enables tailored treatment by wrinkle depth and volumetric requirements.

Indications

Injections aimed at giving volume to the entire face while avoiding the eye contours.
Volumetric correction and reshaping of cheekbones, chin, nasal bridge and lips.
Treatment and reduction of medium-to-deep facial wrinkles and folds (e.g. nasolabial and marionette lines).
Increase in volume of the cheekbones, chin, nose and lips, as well as correction of facial furrows.